Detalhe da pesquisa
1.
CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies.
Blood
; 140(1): 38-44, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421218
2.
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial.
Haematologica
; 109(2): 543-552, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37560813
3.
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia.
Blood
; 137(14): 1879-1894, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33150388
4.
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials.
Haematologica
; 108(4): 969-980, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36325893
5.
Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain.
Eur J Haematol
; 111(3): 485-490, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381686
6.
Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocols.
Br J Haematol
; 196(3): 670-675, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34549416
7.
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications.
Histopathology
; 81(6): 826-840, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36109172
8.
Long-term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab.
Cancer
; 127(4): 554-559, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33141929
9.
Pembrolizumab for refractory primary mediastinal B-cell lymphoma with central nervous system involvement.
Hematol Oncol
; 39(3): 419-422, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33369766
10.
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials.
Hematol Oncol
; 39(4): 529-538, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34405901
11.
Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia.
Cancer
; 126(2): 304-310, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31626339
12.
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.
N Engl J Med
; 376(9): 836-847, 2017 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28249141
13.
JZP458 closes the asparaginase allergy gap.
Blood
; 141(7): 685-686, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795447
14.
T-ALL in CNS-3 status needs improvement.
Blood
; 141(15): 1779-1780, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37052942
15.
Long-term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first-line therapy: A retrospective analysis from two institutions.
Eur J Haematol
; 104(3): 198-206, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769545
16.
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols.
Eur J Haematol
; 105(2): 138-147, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32243655
17.
Impact of detectable measurable residual disease on umbilical cord blood transplantation.
Am J Hematol
; 95(9): 1057-1065, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32449964
18.
Molecular profiling refines minimal residual disease-based prognostic assessment in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.
Genes Chromosomes Cancer
; 58(11): 815-819, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340073
19.
Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus-related Lymphomas.
Clin Infect Dis
; 68(5): 834-843, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29982484
20.
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(8): 1498-1504, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31002989